CD4 mimetics (Harvard Medical Science/University of California/Duke University/University of Pennsylvania/Karolinska Institutet)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameCD4 mimetics (Harvard Medical Science/University of California/Duke University/University of Pennsylvania/Karolinska Institutet)
Drug Alias Name(R,R)-JP-III-048(+)-(R,R)-BNM-III-170(+)-(R,R)-BNM-IV-147BNM-IV-147JRC-II-191 +[7] 
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionHIV envelope protein gp120 inhibitorsHIV uptake inhibitorsT-cell surface antigen CD4 modulators
TargetsHIV envelope protein gp120T-cell surface antigen CD4
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHarvard Medical School
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of CaliforniaDuke UniversityHarvard Medical School +[5] 
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A